Rapafusyn Pharmaceuticals
Rapafusyn Pharmaceuticals, based in Baltimore, MD, is at the forefront of drug development, specializing in a unique approach known as RapaGlues™, which are non-degrading molecular glues designed to target previously undruggable proteins. Their innovative platform leverages the natural binding mechanism of FKBP12 to create selective and tunable therapeutic options for a wide range of intracellular and transmembrane proteins.
Led by a seasoned team of drug development experts, Rapafusyn is dedicated to advancing novel therapies for underserved patient populations. With ongoing partnerships and a robust pipeline, the company aims to reshape the landscape of medicine through its cutting-edge research and development efforts.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.